Skip to main content
RUNBEN BIOTECHNOLOGY CO., LTD. logo

RUNBEN BIOTECHNOLOGY CO., LTD. — Investor Relations & Filings

Ticker · 603193 ISIN · CNE100006DK5 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 269 across all filing types
Latest filing 2023-10-26 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603193

About RUNBEN BIOTECHNOLOGY CO., LTD.

https://www.runben.com/

Runben Biotechnology Co., Ltd. focuses on the research, development, production, and distribution of personal care and household hygiene solutions. The company’s core product portfolio is categorized into mosquito repellents, infant and child care, and essential oil products. Key offerings include electric mosquito repellent liquids, botanical essential oil patches, and specialized skincare items such as moisturizing creams and cleansing products tailored for sensitive skin. Runben prioritizes the integration of biotechnology with natural formulations to ensure product safety and efficacy. By maintaining a strong emphasis on product innovation and quality control, the company serves a broad consumer base through integrated online and offline sales channels, positioning itself as a provider of health-oriented daily necessities for family environments.

Recent filings

Filing Released Lang Actions
第一届监事会第十一次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 11th meeting of the first Supervisory Board of Runben Biotechnology Co., Ltd. It includes approval of the use of raised funds and the review of the company's 2023 third quarter report. The document references the 2023 third quarter report but does not contain the report itself or detailed financial data. It is a meeting resolution announcement related to supervisory board decisions and approvals, not the full quarterly report. The document length is short (1397 characters), and it serves as an official meeting resolution announcement rather than a comprehensive financial report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and meeting resolution disclosure.
2023-10-26 Chinese
公司章程
Governance Information Classification · 100% confidence The document is titled "公司章程" which translates to "Company Articles of Association" or "Company Bylaws." It contains detailed provisions about the company's organization, shareholder rights, board of directors, management, share issuance, shareholder meetings, and other governance-related rules. It references relevant laws and regulatory bodies such as the China Securities Regulatory Commission (中国证监会) and the Shanghai Stock Exchange (上交所). The content is focused on the internal rules and governance structure of the company rather than financial results, audit opinions, or announcements. It is a comprehensive governance document that outlines the company's internal rules and board structure. Therefore, the appropriate classification is Governance Information (CGR).
2023-10-24 Chinese
申万宏源证券承销保荐有限责任公司关于润本生物技术股份有限公司使用部分超募资金永久补充流动资金的核查意见
Regulatory Filings Classification · 95% confidence The document is a verification opinion from the sponsor (申万宏源证券承销保荐有限责任公司) regarding the use of part of the over-raised funds by 润本生物技术股份有限公司 to permanently supplement working capital. It references regulatory guidelines and approvals related to the use of raised funds from an IPO. The document includes details about the fundraising, the amount of over-raised funds, the board and supervisory committee approvals, independent directors' opinions, and the sponsor's verification opinion. It is not the actual financial report or audit report but a regulatory compliance and verification statement related to the use of funds. The document length is about 3,083 characters, which is relatively short and focused on a specific regulatory compliance matter. This fits best under Regulatory Filings (RNS), as it is a regulatory announcement and verification opinion rather than a full financial report or audit report.
2023-10-24 Chinese
关于部分募投项目新增实施主体的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company regarding the addition of a new implementation entity for certain projects funded by proceeds from its initial public offering (IPO). It details the background of the fundraising, the use of funds, the change in project implementation entity, and includes approvals from the board, supervisory board, independent directors, and the sponsor. The document does not contain financial statements or detailed financial performance data but rather focuses on changes related to the use and management of raised capital. It is a regulatory announcement about changes in the use of raised funds and project implementation, not a full financial report or earnings release. The document length is 3640 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under the category of Capital/Financing Update (CAP), as it relates to updates on company fundraising and capital use.
2023-10-24 Chinese
关于变更注册资本、公司类型及修订《公司章程》并办理工商变更登记的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from the company regarding changes in registered capital, company type, and amendments to the company's articles of association (company charter). It includes details about the approval of capital increase following an IPO, changes in company type from non-listed to listed, and specific amendments to the articles of association. The document also references board meeting resolutions and an audit report verifying the capital increase. The document is relatively short (1778 characters) and serves as a formal announcement of these corporate changes and filings, rather than a full report or detailed financial statement. It does not contain comprehensive financial data or detailed management discussion, nor is it a proxy statement or voting result announcement. It is a regulatory announcement about corporate governance and capital structure changes. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-10-24 Chinese
关于使用部分暂时闲置募集资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by a company regarding the use of temporarily idle raised funds for cash management. It details the investment amount, purpose, risk analysis, approvals by the board and supervisory committee, and independent opinions. It references regulatory approvals and compliance with stock exchange rules. The document is a formal announcement about the company's capital management activities related to raised funds, not a full financial report or audit. It is not an annual or interim report, earnings release, or management discussion. It is specifically about the use of raised funds and cash management, which fits the category of Capital/Financing Update (CAP). The document length is about 4,426 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the best classification is CAP with high confidence.
2023-10-24 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.